DE1252898B
(de)
|
1965-06-12 |
1967-10-26 |
Bayer Ag |
Verfahren zur Herstellung von Copolymerisaten des Trioxans
|
US5240928A
(en)
|
1989-07-03 |
1993-08-31 |
Merck & Co., Inc. |
Substituted quinazolinones as angiotensin II antagonists
|
DE3930262A1
(de)
|
1989-09-11 |
1991-03-21 |
Thomae Gmbh Dr K |
Kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
|
KR910009330B1
(ko)
|
1989-10-23 |
1991-11-11 |
재단법인 한국화학연구소 |
항균작용을 갖는 퀴놀린계 화합물과 그의 제조방법
|
CA2037630C
(en)
|
1990-03-07 |
2001-07-03 |
Akira Morimoto |
Nitrogen-containing heterocylic compounds, their production and use
|
US5470975A
(en)
|
1990-10-16 |
1995-11-28 |
E.R. Squibb & Sons, Inc. |
Dihydropyrimidine derivatives
|
US5290780A
(en)
|
1991-01-30 |
1994-03-01 |
American Cyanamid Co. |
Angiotensin II receptor blocking 2,3,6 substituted quinazolinones
|
US5238942A
(en)
|
1991-05-10 |
1993-08-24 |
Merck & Co., Inc. |
Substituted quinazolinones bearing acidic functional groups as angiotensin ii antagonists
|
DE4121214A1
(de)
|
1991-06-27 |
1993-01-14 |
Bayer Ag |
7-azaisoindolinyl-chinolon- und -naphthyridoncarbonsaeure-derivate
|
US5202322A
(en)
|
1991-09-25 |
1993-04-13 |
Merck & Co., Inc. |
Quinazolinone and pyridopyrimidine a-II antagonists
|
US5532243A
(en)
|
1992-02-14 |
1996-07-02 |
The Dupont Merck Pharmaceutical Company |
Antipsychotic nitrogen-containing bicyclic compounds
|
US5358951A
(en)
|
1993-04-23 |
1994-10-25 |
American Cyanamid Company |
Angiotensin II receptor blocking 2, 3, 6 substituted quinazolinones
|
DE4407047A1
(de)
|
1994-03-03 |
1995-09-07 |
Merck Patent Gmbh |
Acetamide
|
US20010016657A1
(en)
|
1997-03-18 |
2001-08-23 |
Smithkline Beecham P.L.C. |
Substituted isoquinoline derivatives and their use as anticonvulsants
|
HUP0102404A2
(hu)
|
1998-02-04 |
2001-11-28 |
Banyu Pharmaceutical Co., Ltd. |
N-acilezett gyűrűs aminszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyászati készítmények
|
JP2001039950A
(ja)
|
1999-07-30 |
2001-02-13 |
Banyu Pharmaceut Co Ltd |
N−アシル環状アミン誘導体
|
CA2389034A1
(en)
|
1999-10-27 |
2001-05-03 |
Cor Therapeutics, Inc. |
Pyridyl-containing spirocyclic compounds as inhibitors of fibrinogen-dependent platelet aggregation
|
JP2004529113A
(ja)
|
2001-03-07 |
2004-09-24 |
ファイザー・プロダクツ・インク |
ケモカイン受容体活性のモジュレーター
|
EP1499306A4
(en)
|
2002-04-12 |
2007-03-28 |
Merck & Co Inc |
BICYCLIC AMIDE
|
GB0303852D0
(en)
|
2003-02-19 |
2003-03-26 |
Pfizer Ltd |
Triazole compounds useful in therapy
|
WO2005023762A1
(en)
|
2003-09-04 |
2005-03-17 |
Abbott Laboratories |
Pyrrolidine-2-carbonitrile derivatives and their use as inhibitors of dipeptidyl peptidase-iv (dpp-iv)
|
SE0302811D0
(sv)
|
2003-10-23 |
2003-10-23 |
Astrazeneca Ab |
Novel compounds
|
GB0324790D0
(en)
|
2003-10-24 |
2003-11-26 |
Astrazeneca Ab |
Amide derivatives
|
US7226951B2
(en)
|
2003-12-17 |
2007-06-05 |
Allergan, Inc. |
Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same
|
KR100610731B1
(ko)
|
2004-02-24 |
2006-08-09 |
한국과학기술연구원 |
T-형 칼슘 채널 차단제로서 유용한 3,4-디히드로퀴나졸린유도체 및 그의 제조 방법
|
JP4845873B2
(ja)
|
2004-03-03 |
2011-12-28 |
ケモセントリックス インコーポレーティッド |
二環式および架橋した窒素複素環
|
BRPI0511982A
(pt)
|
2004-06-09 |
2008-01-22 |
Hoffmann La Roche |
compostos antiviróticos heterocìclicos
|
RU2401833C2
(ru)
|
2004-08-10 |
2010-10-20 |
Янссен Фармацевтика Н.В. |
Производные 1, 2, 4-триазин-6-она, ингибирующие вич
|
US7410949B2
(en)
|
2005-01-18 |
2008-08-12 |
Hoffmann-La Roche Inc. |
Neuropeptide-2 receptor (Y-2R) agonists and uses thereof
|
GB0504019D0
(en)
|
2005-02-26 |
2005-04-06 |
Astrazeneca Ab |
Amide derivatives
|
CN101166736B
(zh)
|
2005-04-28 |
2013-02-06 |
惠氏公司 |
他那普戈特的多晶型ⅱ
|
US7737279B2
(en)
|
2005-05-10 |
2010-06-15 |
Bristol-Myers Squibb Company |
1,6-dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same
|
TW200800999A
(en)
|
2005-09-06 |
2008-01-01 |
Astrazeneca Ab |
Novel compounds
|
PT1942108E
(pt)
|
2005-10-28 |
2013-10-24 |
Ono Pharmaceutical Co |
Composto com um grupo básico e a sua utilização
|
PL1961744T3
(pl)
|
2005-11-18 |
2013-09-30 |
Ono Pharmaceutical Co |
Związek zawierający grupę zasadową oraz jego zastosowanie
|
JP2007176809A
(ja)
|
2005-12-27 |
2007-07-12 |
Hideaki Natsukari |
複素環置換アミド化合物、その製造法および医薬組成物
|
WO2007103719A2
(en)
|
2006-03-03 |
2007-09-13 |
Incyte Corporation |
MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
|
JP2008031064A
(ja)
|
2006-07-27 |
2008-02-14 |
Astellas Pharma Inc |
ジアシルピペラジン誘導体
|
NZ575426A
(en)
|
2006-09-11 |
2010-09-30 |
Organon Nv |
Quinazolinone and isoquinolinone acetamide derivatives useful for the treatment of disorders which are influenced by modulation of the activity of the hpa axis
|
MX2009002923A
(es)
|
2006-09-15 |
2009-03-31 |
Schering Corp |
Derivados de azetidina espiro condensados utiles en el tratamiento del dolor, diabetes y trastornos del metabolismo de los lipidos.
|
US8735411B2
(en)
|
2006-10-02 |
2014-05-27 |
Abbvie Inc. |
Macrocyclic benzofused pyrimidine derivatives
|
TWI404532B
(zh)
|
2006-11-02 |
2013-08-11 |
Targacept Inc |
菸鹼乙醯膽鹼受體亞型選擇性之二氮雜雙環烷類醯胺
|
EP2097388B1
(en)
|
2006-11-15 |
2011-09-07 |
High Point Pharmaceuticals, LLC |
Novel 2-(2-hydroxyphenyl)benzimidazoles useful for treating obesity and diabetes
|
TW200831085A
(en)
|
2006-12-13 |
2008-08-01 |
Merck & Co Inc |
Non-nucleoside reverse transcriptase inhibitors
|
EP1975165A1
(de)
|
2007-03-27 |
2008-10-01 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Substituierte Pyrrolidinamide, deren Herstellung und deren Verwendung als Arzneimittel
|
AU2008233929A1
(en)
|
2007-03-29 |
2008-10-09 |
F. Hoffmann-La Roche Ag |
Non-nucleoside reverse transcriptase inhibitors
|
CL2008001002A1
(es)
|
2007-04-11 |
2008-10-17 |
Actelion Pharmaceuticals Ltd |
Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
|
ATE489389T1
(de)
|
2007-04-27 |
2010-12-15 |
Sanofi Aventis |
2 -heteroaryl- pyrrolo ä3, 4-cüpyrrol- derivate und deren verwendung als scd inhibitoren
|
CA2691529C
(en)
|
2007-08-07 |
2016-01-05 |
Abbott Gmbh & Co. Kg |
Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
|
DE102007047737A1
(de)
|
2007-10-05 |
2009-04-30 |
Merck Patent Gmbh |
Piperidin- und Piperazinderivate
|
CA2958665C
(en)
|
2007-10-19 |
2021-03-02 |
Sarcode Bioscience Inc. |
Compositions and methods for treatment of diabetic retinopathy
|
TW200932236A
(en)
|
2007-10-31 |
2009-08-01 |
Janssen Pharmaceutica Nv |
Aryl-substituted bridged diamines as modulators of leukotriene A4 hydrolase
|
JP2009161449A
(ja)
|
2007-12-28 |
2009-07-23 |
Lion Corp |
Ppar活性促進剤並びに美容用飲食品、皮膚外用剤及び医薬
|
EP2301936A1
(en)
|
2008-06-19 |
2011-03-30 |
Banyu Pharmaceutical Co., Ltd. |
Spirodiamine-diarylketoxime derivative
|
EP2328898B1
(de)
|
2008-09-09 |
2014-12-24 |
Sanofi |
2-heteroaryl-pyrrolo[3,4-c]pyrrol- derivate und ihre verwendung als scd inhibitoren
|
TW201020247A
(en)
|
2008-11-06 |
2010-06-01 |
Gruenenthal Gmbh |
Substituierte disulfonamide
|
CA2739725A1
(en)
|
2008-11-17 |
2010-05-20 |
F. Hoffmann-La Roche Ag |
Naphthylacetic acids used as crth2 antagonists or partial agonists
|
DE102008059578A1
(de)
|
2008-11-28 |
2010-06-10 |
Merck Patent Gmbh |
Benzo-Naphtyridin Verbindungen
|
WO2010063352A1
(en)
|
2008-12-01 |
2010-06-10 |
Merck Patent Gmbh |
2, 5-diamino-substituted pyrido [4, 3-d] pyrimidines as autotaxin inhibitors against cancer
|
TW201035102A
(en)
|
2009-03-04 |
2010-10-01 |
Gruenethal Gmbh |
Sulfonylated tetrahydroazolopyrazines and their use as medicinal products
|
MX2011009244A
(es)
|
2009-03-05 |
2011-09-26 |
Daiichi Sankyo Co Ltd |
Derivado de piridina.
|
US20120010186A1
(en)
|
2009-03-23 |
2012-01-12 |
Merck Frosst Canada Ltd. |
Heterocyclic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
TW201038572A
(en)
|
2009-03-25 |
2010-11-01 |
Gruenenthal Gmbh |
Substituted spiro-amide compounds
|
EA201101400A1
(ru)
|
2009-04-02 |
2012-07-30 |
Мерк Патент Гмбх |
Производные пиперидина и пиразина в качестве ингибиторов аутотаксина
|
CA2757415C
(en)
|
2009-04-02 |
2018-02-06 |
Merck Patent Gmbh |
Autotaxin inhibitors
|
EP2414327B1
(de)
|
2009-04-02 |
2014-11-19 |
Merck Patent GmbH |
Heterocyclische verbindungen als autotaxin-inhibitoren
|
FR2945534B1
(fr)
|
2009-05-12 |
2012-11-16 |
Sanofi Aventis |
DERIVES DE CYCLOPENTAL[c]PYRROLE-2-CARBOXYLATES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
|
MX2011012345A
(es)
|
2009-05-22 |
2012-01-31 |
Exelixis Inc |
Inhibidores de pi3k/mtor basados en benzoxazepinas contra enfermedades proliferativas.
|
US20120083476A1
(en)
|
2009-06-05 |
2012-04-05 |
Janssen Pharmaceutica Nv |
Heteroaryl-substituted spirocyclic diamine urea modulators of fatty acid amide hydrolase
|
DE102009033392A1
(de)
|
2009-07-16 |
2011-01-20 |
Merck Patent Gmbh |
Heterocyclische Verbindungen als Autotaxin-Inhibitoren II
|
IN2012DN00754A
(es)
|
2009-08-04 |
2015-06-19 |
Amira Pharmaceuticals Inc |
|
UA107360C2
(en)
|
2009-08-05 |
2014-12-25 |
Biogen Idec Inc |
Bicyclic aryl sphingosine 1-phosphate analogs
|
AR079022A1
(es)
|
2009-11-02 |
2011-12-21 |
Sanofi Aventis |
Derivados de acido carboxilico ciclico sustituidos con acilamino, su uso como productos farmaceuticos, composicion farmaceutica y metodo de preparacion
|
AU2011204323B2
(en)
|
2010-01-07 |
2013-12-12 |
E. I. Du Pont De Nemours And Company |
Fungicidal heterocyclic compounds
|
US8815869B2
(en)
|
2010-03-18 |
2014-08-26 |
Abbvie Inc. |
Lactam acetamides as calcium channel blockers
|
EP2547679B1
(en)
|
2010-03-19 |
2015-11-04 |
Pfizer Inc |
2,3 dihydro-1h-inden-1-yl-2,7-diazaspiro[3.6]nonane derivatives and their use as antagonists or inverse agonists of the ghrelin receptor
|
ES2562183T3
(es)
|
2010-03-26 |
2016-03-02 |
Merck Patent Gmbh |
Benzonaftiridinaminas como inhibidores de la autotaxina
|
GB201008005D0
(en)
|
2010-05-13 |
2010-06-30 |
Sentinel Oncology Ltd |
Pharmaceutical compounds
|
WO2011151461A2
(en)
|
2010-06-04 |
2011-12-08 |
B.S.R.C. "Alexander Fleming" |
Autotaxin pathway modulation and uses thereof
|
AR082590A1
(es)
|
2010-08-12 |
2012-12-19 |
Hoffmann La Roche |
Inhibidores de la tirosina-quinasa de bruton
|
JP2013536200A
(ja)
|
2010-08-20 |
2013-09-19 |
アミラ ファーマシューティカルス,インコーポレーテッド |
オートタキシン阻害剤およびその使用
|
EP2611808B1
(en)
|
2010-09-02 |
2014-11-12 |
Merck Patent GmbH |
Pyrazolopyridinone derivatives as lpa receptor antagonists
|
KR101528688B1
(ko)
|
2010-12-02 |
2015-06-12 |
상하이 드 노보 파마테크 컴퍼니 리미티드 |
헤테로사이클릭 유도체, 이의 제조 방법 및 이의 의학적 용도
|
WO2012080727A2
(en)
|
2010-12-14 |
2012-06-21 |
Electrophoretics Limited |
Casein kinase 1delta (ck1delta) inhibitors
|
EP2714680B1
(en)
|
2011-05-27 |
2015-11-25 |
Amira Pharmaceuticals, Inc. |
Heterocyclic autotaxin inhibitors and uses thereof
|
ES2609579T3
(es)
|
2011-08-29 |
2017-04-21 |
VIIV Healthcare UK (No.5) Limited |
Derivados espiro de diamina bicíclica como inhibidores de la unión del VIH
|
WO2013054185A1
(en)
|
2011-10-13 |
2013-04-18 |
Pfizer, Inc. |
Pyrimidine and pyridine derivatives useful in therapy
|
JPWO2013065712A1
(ja)
|
2011-10-31 |
2015-04-02 |
東レ株式会社 |
ジアザスピロウレア誘導体及びその医薬用途
|
US8809552B2
(en)
|
2011-11-01 |
2014-08-19 |
Hoffmann-La Roche Inc. |
Azetidine compounds, compositions and methods of use
|
JP5918859B2
(ja)
|
2011-12-02 |
2016-05-18 |
フェネックス ファーマシューティカルス アーゲー |
オーファン核内受容体RARに関連するオーファン受容体−ガンマ(RORγ、NR1F3)活性の調整剤としての、慢性の炎症性疾患および自己免疫性疾患を治療するためのピロロカルボキサミド
|
TWI638802B
(zh)
|
2012-05-24 |
2018-10-21 |
芬蘭商奧利安公司 |
兒茶酚o-甲基轉移酶活性抑制化合物
|
DK2861595T5
(en)
|
2012-06-13 |
2018-01-15 |
Incyte Holdings Corp |
Substituted tricyclic compounds as FGFR inhibitors
|
IN2014DN09346A
(es)
|
2012-06-13 |
2015-07-17 |
Hoffmann La Roche |
|
RU2665462C2
(ru)
|
2012-06-27 |
2018-08-30 |
Ф. Хоффманн-Ля Рош Аг |
Соединения 5-азаиндазола и способы их применения
|
ES2668694T3
(es)
|
2012-07-27 |
2018-05-21 |
Biogen Ma Inc. |
Derivados de ácido 1-[7-(cis-4-metil-ciclohexiloxi)-8-trifluorometil-naftalen-2-ilmetil]-piperidin-4-carboxílico como moduladores de autotaxina (ATX) para tratar inflamaciones y trastornos autoinmunitarios
|
ES2671194T3
(es)
|
2012-07-27 |
2018-06-05 |
Biogen Ma Inc. |
Compuestos que son agentes moduladores de S1P y/o agentes moduladores de ATX
|
AR092211A1
(es)
|
2012-09-24 |
2015-04-08 |
Merck Patent Ges Mit Beschränkter Haftung |
Derivados de hidropirrolopirrol
|
WO2014048865A1
(en)
*
|
2012-09-25 |
2014-04-03 |
F. Hoffmann-La Roche Ag |
New bicyclic derivatives
|
MX357035B
(es)
|
2012-09-25 |
2018-06-25 |
Bayer Pharma AG |
Combinacion de regorafenib y acido acetilsalicilico para el tratamiento del cancer.
|
AR092742A1
(es)
|
2012-10-02 |
2015-04-29 |
Intermune Inc |
Piridinonas antifibroticas
|
PT2912019T
(pt)
|
2012-10-25 |
2021-05-25 |
Tetra Discovery Partners Llc |
Inibidores heteroarilo da pde4
|
US9598418B2
(en)
|
2012-12-31 |
2017-03-21 |
Cadila Healthcare Limited |
Substituted phthalazin-1 (2H)-one derivatives as selective inhibitors of poly (ADP-ribose) polymerase-1
|
WO2014133112A1
(ja)
|
2013-03-01 |
2014-09-04 |
国立大学法人東京大学 |
オートタキシン阻害活性を有する8-置換イミダゾピリミジノン誘導体
|
AR095079A1
(es)
|
2013-03-12 |
2015-09-16 |
Hoffmann La Roche |
Derivados de octahidro-pirrolo[3,4-c]-pirrol y piridina-fenilo
|
BR112015022041A2
(pt)
|
2013-03-12 |
2017-07-18 |
Acucela Inc |
derivados substituídos de 3-fenilpropilamina para o tratamento de doenças e distúrbios oftálmicas
|
TWI593692B
(zh)
|
2013-03-12 |
2017-08-01 |
美國禮來大藥廠 |
四氫吡咯并噻嗪化合物
|
SG11201507402WA
(en)
|
2013-03-12 |
2015-10-29 |
Abbvie Inc |
Tetracyclic bromodomain inhibitors
|
WO2014152725A1
(en)
|
2013-03-15 |
2014-09-25 |
Biogen Idec Ma Inc. |
S1p and/or atx modulating agents
|
CU24355B1
(es)
|
2013-07-18 |
2018-08-06 |
Novartis Ag |
Derivados de 2((( oxadiazol/triazol/tetrazol/isoxazol) metil) fenil)-1-(heterociclil)-ona como inhibidores activos de autotaxina
|
LT3057959T
(lt)
|
2013-10-17 |
2018-06-11 |
Vertex Pharmaceuticals Incorporated |
Dnr-pk inhibitoriai
|
PE20160654A1
(es)
|
2013-11-22 |
2016-07-15 |
Pharmakea Inc |
Compuestos de inhibidor de autotaxina
|
AR098475A1
(es)
|
2013-11-26 |
2016-06-01 |
Bayer Cropscience Ag |
Compuestos pesticidas y usos
|
MA38982A1
(fr)
|
2013-11-26 |
2017-09-29 |
Hoffmann La Roche |
Nouvel octahydro-cyclobuta [1,2-c; 3,4-c'] dipyrrol-2-yl
|
DK3122750T3
(da)
|
2014-03-26 |
2019-11-04 |
Hoffmann La Roche |
Bicykliske forbindelser som autotaxin (ATX)- og lysofosfatidsyre (LPA)-produktionshæmmere
|
JO3512B1
(ar)
|
2014-03-26 |
2020-07-05 |
Astex Therapeutics Ltd |
مشتقات كينوكسالين مفيدة كمعدلات لإنزيم fgfr كيناز
|
CA2939865A1
(en)
|
2014-03-26 |
2015-10-01 |
Basf Se |
Substituted [1,2,4]triazole and imidazole compounds as fungicides
|
EA032357B1
(ru)
|
2014-03-26 |
2019-05-31 |
Ф. Хоффманн-Ля Рош Аг |
Конденсированные [1,4]диазепиновые соединения в качестве ингибиторов продукции аутотаксина (atx) и лизофосфатидиловой кислоты (lpa)
|
JP6616821B2
(ja)
|
2014-04-04 |
2019-12-04 |
エックス−アールエックス, インコーポレイテッド |
オートタキシンの置換スピロ環式阻害剤
|
WO2016031987A1
(ja)
|
2014-08-29 |
2016-03-03 |
国立大学法人東京大学 |
オートタキシン阻害活性を有するピリミジノン誘導体
|
CA2963140A1
(en)
|
2014-10-14 |
2016-04-21 |
Vitae Pharmaceuticals, Inc. |
Dihydropyrrolopyridine inhibitors of ror-gamma
|
CN107922392B
(zh)
|
2015-02-15 |
2020-07-21 |
豪夫迈·罗氏有限公司 |
1-(杂)芳基磺酰基-(吡咯烷或哌啶)-2-甲酰胺衍生物及其用途
|
MA41898A
(fr)
|
2015-04-10 |
2018-02-13 |
Hoffmann La Roche |
Dérivés de quinazolinone bicyclique
|
CN104927727B
(zh)
|
2015-07-06 |
2017-01-11 |
香山红叶建设有限公司 |
一种玻璃幕墙用结构密封胶及其制备方法
|
PL415078A1
(pl)
|
2015-09-04 |
2017-03-13 |
Oncoarendi Therapeutics Spółka Z Ograniczoną Odpowiedzialnością |
Podstawione aminotriazole przydatne jako inhibitory kwaśnej chitynazy ssaków
|
MX2020004504A
(es)
|
2015-09-04 |
2021-11-10 |
Hoffmann La Roche |
Derivados de fenoximetilo.
|
RU2018113709A
(ru)
|
2015-09-24 |
2019-10-30 |
Айонис Фармасьютикалз, Инк. |
Модуляторы экспрессии kras
|
BR112017026682A2
(pt)
|
2015-09-24 |
2018-08-14 |
Hoffmann La Roche |
novos compostos bicíclicos como inibidores de dupla ação de atx/ca
|
WO2017050791A1
(en)
|
2015-09-24 |
2017-03-30 |
F. Hoffmann-La Roche Ag |
New bicyclic compounds as dual atx/ca inhibitors
|
CA2983782A1
(en)
|
2015-09-24 |
2017-03-30 |
F. Hoffmann-La Roche Ag |
Bicyclic compounds as atx inhibitors
|
MX2018001890A
(es)
|
2015-09-24 |
2018-06-20 |
Hoffmann La Roche |
Compuestos biciclicos como inhibidores de autotaxina (atx).
|
US10385057B2
(en)
|
2015-11-20 |
2019-08-20 |
Lundbeck La Jolla Research Center, Inc. |
Pyrazole compounds and methods of making and using same
|
WO2017087863A1
(en)
|
2015-11-20 |
2017-05-26 |
Abide Therapeutics, Inc. |
Pyrazole compounds and methods of making and using same
|
CA3003288A1
(en)
|
2015-11-25 |
2017-06-01 |
Dana-Farber Cancer Institute, Inc. |
Bivalent bromodomain inhibitors and uses thereof
|
CN108290858B
(zh)
|
2015-12-01 |
2021-07-06 |
日本农药株式会社 |
3h-吡咯并吡啶化合物或其n-氧化物、或它们的盐类及含有该化合物的农业园艺用杀虫剂及其使用方法
|
WO2017139978A1
(zh)
|
2016-02-19 |
2017-08-24 |
吴伟东 |
手机app更新方法及系统
|
CN110382484B
(zh)
|
2017-03-16 |
2022-12-06 |
豪夫迈·罗氏有限公司 |
新的作为atx抑制剂的二环化合物
|
KR20190129924A
(ko)
|
2017-03-16 |
2019-11-20 |
에프. 호프만-라 로슈 아게 |
이중 오토탁신(atx)/탄산 무수화효소(ca) 억제제로서 유용한 헤테로환형 화합물
|
MX2018014032A
(es)
|
2017-03-20 |
2019-08-21 |
Forma Therapeutics Inc |
Composiciones de pirrolopirrol como activadores de piruvato cinasa (pkr).
|